)
Linc (LINC) investor relations material
Linc Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Substantial recovery in asset values during Q2 2026, driven by strong performance in MedCap and Stille, despite high market volatility and geopolitical uncertainty.
Net asset value (NAV) per share increased by 6.1% in Q2 2026 and 1.8% for H1 2026, reversing last year's negative trend.
Portfolio strategy focused on opportunistic, long-term investments in Nordic life science companies with global potential.
Financial highlights
Q2 2026: Management result SEK 244.5m (367.6m), EBIT SEK 241.1m (364.8m), net profit SEK 258.1m (350.8m), EPS SEK 4.5 (6.1).
H1 2026: Management result SEK 82.1m (-646.8m), EBIT SEK 75.4m (-653.1m), net profit SEK 81.2m (-645.2m), EPS SEK 1.4 (-11.1).
NAV at period end SEK 4,508.8m, NAV per share SEK 77.9.
Solid equity ratio of 99.8%, net cash position of SEK 170.0m.
Outlook and guidance
Well-positioned to capitalize on market opportunities with a strong balance sheet.
Continued focus on selective investments in companies with clear clinical and commercial potential.
Market volatility and geopolitical risks expected to persist.
- NAV per share declined 4.0% in Q1 2026, with improved results and selective portfolio gains.LINC
Q1 202623 Apr 2026 - Sharp decline in net asset value and earnings in 2025, with no dividend proposed.LINC
Q4 202522 Jan 2026 - Strong Q3 rebound with 8.5% NAV return, MedCap leads gains, biotech sector shows early recovery.LINC
Q3 202523 Oct 2025 - H1 2025 marked sharp portfolio swings but Q2 recovery and strategic investments support future growth.LINC
Q2 202517 Jul 2025 - 30.9% NAV return YTD, major Calliditas exit, strong MedCap and Stille, biotech lagged.LINC
Q3 202413 Jun 2025 - Q2 net profit surged to SEK 1,040.9m with 29% NAV return, led by MedCap and Calliditas.LINC
Q2 202413 Jun 2025 - Net asset value return fell to -20.6% as MedCap and Sedana Medical saw sharp declines.LINC
Q1 20256 Jun 2025 - Net asset value per share surged 36.9% in 2024, led by MedCap and Calliditas gains.LINC
Q4 20245 Jun 2025
Next Linc earnings date
Next Linc earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)